Advertisement

Genome-Wide Studies in Adrenocortical Neoplasia

  • Thomas J. Giordano
Chapter

Abstract

In the not too distant past, there existed a mystique amongst pathologists, radiologists, and clinicians regarding neoplasms of the adrenal cortex. Specifically, there was a belief by some that it was not possible to accurately classify adrenal tumors into benign and malignant categories in the absence of metastatic disease. It was this mystical quality that led Larry Weiss and his colleagues to systematically examine the histopathology of a series of adrenocortical tumors and thus derive the evaluation system that bears his name [1, 2].

Keywords

Copy Number Change Adrenocortical Carcinoma Pediatric Tumor Adrenocortical Tumor Normal Cortex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757–768CrossRefPubMedGoogle Scholar
  2. 2.
    Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163–169CrossRefPubMedGoogle Scholar
  3. 3.
    van Slooten H et al (1985) Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 55:766–773CrossRefPubMedGoogle Scholar
  4. 4.
    Giordano TJ et al (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162:521–531PubMedGoogle Scholar
  5. 5.
    Barlaskar FM, Hammer GD (2007) The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord 8:343–348CrossRefPubMedGoogle Scholar
  6. 6.
    Bertherat J, Gimenez-Roqueplo AP (2005) New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 37:384–390CrossRefPubMedGoogle Scholar
  7. 7.
    Libe R, Bertherat J (2005) Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 153:477–487CrossRefPubMedGoogle Scholar
  8. 8.
    Stratakis CA (2003) Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 14:404–410CrossRefPubMedGoogle Scholar
  9. 9.
    de Fraipont F et al (2005) Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab 90:1819–1829CrossRefPubMedGoogle Scholar
  10. 10.
    Slater EP et al (2006) Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol 154:587–598CrossRefPubMedGoogle Scholar
  11. 11.
    Velazquez-Fernandez D et al (2005) Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138:1087–1094CrossRefPubMedGoogle Scholar
  12. 12.
    de Reynies A et al (2009) Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27:1108–1115CrossRefPubMedGoogle Scholar
  13. 13.
    Giordano TJ et al (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15:668–676CrossRefPubMedGoogle Scholar
  14. 14.
    Laurell C et al (2009) Transcriptional profiling enables molecular classification of adrenocortical tumours. Eur J Endocrinol 161:141–152CrossRefPubMedGoogle Scholar
  15. 15.
    West AN et al (2007) Gene expression profiling of childhood adrenocortical tumors. Cancer Res 67:600–608CrossRefPubMedGoogle Scholar
  16. 16.
    Higgins RA et al (2008) Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia. Mol Diagn Ther 12:271–280PubMedGoogle Scholar
  17. 17.
    Mantripragada KK et al (2004) Genomic microarrays in the spotlight. Trends Genet 20:87–94CrossRefPubMedGoogle Scholar
  18. 18.
    Stephan EA et al (2008) Adrenocortical carcinoma survival rates correlated to genomic copy number variants. Mol Cancer Ther 7:425–431CrossRefPubMedGoogle Scholar
  19. 19.
    Tombol Z et al (2009) Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer 16:895–906CrossRefPubMedGoogle Scholar
  20. 20.
    Kunz M (2008) Genomic signatures for individualized treatment of malignant tumors. Curr Drug Discov Technol 5:9–14CrossRefPubMedGoogle Scholar
  21. 21.
    Potti A, Nevins JR (2008) Utilization of genomic signatures to direct use of primary chemotherapy. Curr Opin Genet Dev 18:62–67CrossRefPubMedGoogle Scholar
  22. 22.
    Wulfkuhle J et al (2004) Genomic and proteomic technologies for individualisation and improvement of cancer treatment. Eur J Cancer 40:2623–2632CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Departments of Pathology and Internal MedicineUniversity of Michigan Health System, University of MichiganAnn ArborUSA

Personalised recommendations